01/28/2025
7:00 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
4:28 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:29 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:30 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:31 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
5:07 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Leap Therapeutics (Subject)
| Form SC 13G | |
11/13/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
5:29 PM | BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
| Form SC 13D/A | |
10/31/2024
4:40 PM | BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
10/04/2024
4:22 PM | Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for LPTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/04/2024
4:23 PM | Baum Jason (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:23 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:23 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:25 PM | Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:25 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:25 PM | Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:26 PM | Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:27 PM | Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:29 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:29 PM | Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:30 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024
3:48 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
11:15 PM | Leap Therapeutics (Filer)
| Form EFFECT | |
05/13/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
4:01 PM | Leap Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/09/2024
11:15 PM | Leap Therapeutics (Filer)
| Form EFFECT | |
04/29/2024
3:34 PM | Leap Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
3:37 PM | Leap Therapeutics (Filer)
| Form ARS | |
04/25/2024
7:39 PM | Leap Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G | |
04/19/2024
3:31 PM | GILEAD SCIENCES, INC. (Reporting)
Leap Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/19/2024
3:31 PM | GILEAD SCIENCES, INC. (Filed by)
Leap Therapeutics (Subject)
| Form SC 13G | |
04/11/2024
7:42 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:41 AM | Leap Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Is this Elon’s true agenda? (Ad) All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them Click here for my report |
03/18/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
